XML 41 R30.htm IDEA: XBRL DOCUMENT
v3.24.3

Business Segments (Tables) | 3 Months Ended
--- | ---
Sep. 30, 2024
Business Segments |
Schedule of information regarding reportable segments | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Three Months |
For the Periods Ended September 30 |  | 2024 |  | 2023 |
Net sales |  |  |  |  |  |  |
Animal Health | ​ | $ | 182,523 | ​ | $ | 160,530 | ​
Mineral Nutrition | ​ |  | 59,062 | ​ |  | 56,026 | ​
Performance Products | ​ |  | 18,847 | ​ |  | 14,793 | ​
Total segments | ​ | $ | 260,432 | ​ | $ | 231,349 | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Depreciation and amortization | ​ | ​ | ​ | ​ | ​ | ​ | ​
Animal Health | ​ | $ | 7,663 | ​ | $ | 7,349 | ​
Mineral Nutrition | ​ |  | 516 | ​ |  | 646 | ​
Performance Products | ​ |  | 333 | ​ |  | 426 | ​
Total segments | ​ | $ | 8,512 | ​ | $ | 8,421 | ​
Adjusted EBITDA | ​ | ​ | ​ | ​ | ​ | ​ | ​
Animal Health | ​ | $ | 40,385 | ​ | $ | 28,494 | ​
Mineral Nutrition | ​ |  | 3,762 | ​ |  | 2,881 | ​
Performance Products | ​ |  | 2,288 | ​ |  | 1,409 | ​
Total segments | ​ | $ | 46,435 | ​ | $ | 32,784 | ​
Reconciliation of income before income taxes to Adjusted EBITDA | ​ | ​ | ​ | ​ | ​ | ​ | ​
Income (loss) before income taxes | ​ | $ | 9,620 | ​ | $ | (11,979) | ​
Interest expense, net | ​ |  | 7,641 | ​ |  | 4,564 | ​
Depreciation and amortization – Total segments | ​ |  | 8,512 | ​ |  | 8,421 | ​
Depreciation and amortization – Corporate | ​ |  | 492 | ​ |  | 450 | ​
Corporate costs | ​ | ​ | 15,779 | ​ | ​ | 14,133 | ​
Acquisition-related transaction costs | ​ | ​ | 3,424 | ​ | ​ | — | ​
Pension settlement cost | ​ | ​ | — | ​ | ​ | 10,425 | ​
Stock-based compensation | ​ | ​ | 179 | ​ | ​ | 81 | ​
Phibro Forward income growth initiatives | ​ | ​ | 350 | ​ | ​ | — | ​
Foreign currency losses, net | ​ |  | 438 | ​ |  | 6,689 | ​
Adjusted EBITDA – Total segments | ​ | $ | 46,435 | ​ | $ | 32,784 | ​
Schedule of identifiable assets | ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | September 30, |  | June 30,
As of |  | 2024 |  | 2024
Identifiable assets |  | ​ |  |  | ​ |
Animal Health | ​ | $ | 688,232 | ​ | $ | 684,407
Mineral Nutrition | ​ |  | 66,462 | ​ |  | 67,088
Performance Products | ​ |  | 48,629 | ​ |  | 50,862
Total segments | ​ |  | 803,323 | ​ |  | 802,357
Corporate | ​ |  | 162,966 | ​ |  | 179,827
Total | ​ | $ | 966,289 | ​ | $ | 982,184

X
- Definition Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration